Total Payments
$69,029
2024 Payments
$5,801
Companies
20
Transactions
68
Medicare Patients
349
Medicare Billing
$84,414
Payment Breakdown by Category
Travel$29,271 (42.4%)
Consulting$28,630 (41.5%)
Other$7,760 (11.2%)
Food & Beverage$2,509 (3.6%)
Gifts$860.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $29,271 | 16 | 42.4% |
| Consulting Fee | $28,630 | 9 | 41.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,872 | 7 | 5.6% |
| Food and Beverage | $2,509 | 30 | 3.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,388 | 2 | 3.5% |
| Honoraria | $1,500 | 1 | 2.2% |
| Gift | $860.00 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $33,494 | 6 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $14,821 | 19 | $0 (2023) |
| F. Hoffmann-La Roche AG | $9,465 | 13 | $0 (2024) |
| Amgen Inc. | $3,254 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $2,207 | 6 | $0 (2019) |
| Epizyme, Inc., | $1,500 | 1 | $0 (2021) |
| Genentech, Inc. | $1,423 | 3 | $0 (2022) |
| Sekisui Diagnostics, LLC | $860.00 | 3 | $0 (2024) |
| Roche Products Limited | $845.49 | 3 | $0 (2018) |
| Genentech USA, Inc. | $277.97 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,801 | 9 | F. Hoffmann-La Roche AG ($5,420) |
| 2023 | $8,512 | 9 | E.R. Squibb & Sons, L.L.C. ($7,933) |
| 2022 | $728.43 | 3 | Sekisui Diagnostics, LLC ($350.00) |
| 2021 | $4,273 | 3 | Amgen Inc. ($2,750) |
| 2020 | $503.99 | 1 | Amgen Inc. ($503.99) |
| 2019 | $22,619 | 12 | Celgene Corporation ($19,722) |
| 2018 | $16,477 | 15 | Celgene Corporation ($13,749) |
| 2017 | $10,115 | 16 | E.R. Squibb & Sons, L.L.C. ($6,671) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $75.86 | General |
| Category: Oncology | ||||||
| 04/23/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $4,013.10 | General |
| 04/23/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $845.34 | General |
| 04/23/2024 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $309.22 | General |
| 04/23/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $147.27 | General |
| 04/23/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $105.00 | General |
| 04/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 02/22/2024 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $255.00 | General |
| 01/16/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: Oncology | ||||||
| 12/11/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $9.93 | General |
| 09/21/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $5.17 | General |
| 06/15/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Oncology | ||||||
| 06/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $5,160.00 | General |
| 04/20/2023 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $178.28 | General |
| 04/19/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,580.00 | General |
| 03/24/2023 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $172.94 | General |
| 03/07/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $129.70 | General |
| 01/01/2023 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $255.00 | General |
| 06/05/2022 | Foundation Medicine, Inc. | FOUNDATIONONE CDX (Device) | Food and Beverage | In-kind items and services | $229.00 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2022 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $149.43 | General |
| 01/01/2022 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $350.00 | General |
| 12/22/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 05/26/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Honoraria | Cash or cash equivalent | $1,500.00 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2021 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | Cash or cash equivalent | $23.43 | General |
| Category: Hematology | ||||||
| 02/28/2020 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $503.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 67 | 151 | $57,610 | $15,324 |
| 2022 | 2 | 79 | 192 | $75,180 | $20,101 |
| 2021 | 3 | 97 | 267 | $91,980 | $26,803 |
| 2020 | 3 | 106 | 262 | $103,430 | $22,186 |
Total Patients
349
Total Services
872
Medicare Billing
$84,414
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 41 | 95 | $41,800 | $12,103 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 56 | $15,810 | $3,221 | 20.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 54 | 130 | $57,200 | $16,475 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 62 | $17,980 | $3,625 | 20.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 126 | $55,440 | $17,256 | 31.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 95 | $27,550 | $5,597 | 20.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 23 | 46 | $8,990 | $3,951 | 43.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 53 | 147 | $64,680 | $14,756 | 22.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 22 | 45 | $18,450 | $4,184 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 70 | $20,300 | $3,246 | 16.0% |
About Dr. Hearn Cho, MD
Dr. Hearn Cho, MD is a Hematology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225060080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hearn Cho, MD has received a total of $69,029 in payments from pharmaceutical and medical device companies, with $5,801 received in 2024. These payments were reported across 68 transactions from 20 companies. The most common payment nature is "Travel and Lodging" ($29,271).
As a Medicare-enrolled provider, Cho has provided services to 349 Medicare beneficiaries, totaling 872 services with total Medicare billing of $84,414. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location New York, NY
- Active Since 07/06/2006
- Last Updated 02/25/2019
- Taxonomy Code 207RH0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225060080
Products in Payments
- Revlimid (Drug) $19,745
- TECENTRIQ (Biological) $3,895
- EMPLICITI (Biological) $2,619
- OPDIVO (Biological) $1,691
- TAZVERIK (Drug) $1,500
- Non-Covered Product (Drug) $845.49
- EMPOWER-METAL (Device) $275.85
- FOUNDATIONONE CDX (Device) $229.00
- DARZALEX (Biological) $75.86
- TECVAYLI (Biological) $27.34
- SARCLISA (Biological) $21.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in New York
Dr. Barry Coller, M.d, M.D
Hematology — Payments: $10.2M
Hematology $10.2M
Dr. Dan Douer, M.d, M.D
Hematology — Payments: $665,161
Hematology $665,161
Louis Aledort, Md, MD
Hematology — Payments: $377,491
Hematology $377,491
Michael Mauro, Md, MD
Hematology — Payments: $374,307
Hematology $374,307
Faith Davies, Md, MD
Hematology — Payments: $373,421
Hematology $373,421
Ann Jakubowski, Md, MD
Hematology — Payments: $92,726
Hematology $92,726